Daniel J. Drucker

<i>FTO</i> Obesity Variant Circuitry and Adipocyte Browning in Humans

Melina Claussnitzer, Simon N. Dankel, Kyoung-Han Kim et al. · New England Journal of Medicine · 2015 · 1.3K citations · Full text

Normalization of obesity-associated insulin resistance through immunotherapy

Shawn Winer, Yin Chan, Geoffrey Paltser et al. · Nature Medicine · 2009 · 1.3K citations · Full text

Obesity, Metabolic Syndrome, Insulin Resistance +10

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

Daniel J. Drucker, John B. Buse, Kristin Taylor et al. · The Lancet · 2008 · 1.1K citations

Non-pharmacological Intervention, Diabetes Management, Insulin Management +7

Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways

Kiwon Ban, M. Hossein Noyan-Ashraf, Judith Hoefer et al. · Circulation · 2008 · 1K citations

Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells

Helga Ellingsgaard, Irina Häuselmann, Beat Schuler et al. · Nature Medicine · 2011 · 897 citations · Full text

Inflammation, L Cells, Molecular Physiology +12